Blood tau and glial fibrillary acidic protein levels peaked at 24–72 h and were lower at 3 months after stroke, whereas blood NfL levels continued to increase at 3 months, which makes it a promising biomarker for prognostic prediction after stroke. This evidence concerns the gene GFAP and stroke disorder.